September, 2017. Congrats Eric on your Biochemistry Viewpoint on a novel nucleoside antibiotic that targets bacterial RNA polymerase. Yet again, natural products come to the rescue for identifying novel drug binding sites and modes of action for targeting pathogenic bacteria. 

August, 2017. Congrats Sandhya and Alan on your ACS Chem Bio article defining the structure and function of an unusual intermediate-releasing thioesterase (TE) at the molecular level from the colibactin biosynthetic pathway. This paper provides new insights into the post-translational regulatory aspects of a bacterial genotoxic pathway in the gut linked to colorectal cancer formation. The enzyme was shown at the biochemical level to regulate the release of critical intermediates required for genotoxicity while removing aberrant enzyme products that shut down the enzymatic system. 

July, 2017. Congrats to Eric Trautman for successfully defending his PhD thesis. Good luck with your next steps in consulting. 

July, 2017. We welcome Alexandra (Alex) Gatsios to the lab as a Chemical Biology graduate student from Smith College.  

May, 2017. Congrats Jason for receiving a Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease (PATH) Award. Our PATH project focuses on defining cell-to-cell stress communications in pathogenic bacteria and in human-bacteria interactions. Jason would like to thank Jaymin Patel for bringing a 30-thousand foot vision on paper to nearing practical solutions at the bench. Jason would also like to thank Chung Sub Kim, Hyun Bong Park, and Corey Perez on their associated bacterial cell-to-cell stress communication work. See the associated YaleNews article.

May, 2017. Congrats Jason for receiving the Camille Dreyfus Teacher-Scholar Award

April, 2017. Congrats Jason for being named as a William Raveis Charitable Fund scientist through the Damon Runyon Cancer Research Foundation. The William Raveis Charitable Fund in partnership with the Damon Runyon Foundation has planned a series of events across the Northeast to raise awareness about the importance of more broadly supporting cancer research. 

February, 2017. Congrats Hyun Bong, Corey, and Karl on your paper being accepted to eLife. This study identifies the first example of a hybrid nonribosomal peptide synthetase-like-pteridine synthase biosynthetic gene cluster.  The paper describes synteny-based genome mining, genetics, pathway-targeted metabolomics, and quantitative proteomics analyses that led to the new metabolite structures encoded by the unprecedented pathway, the “pepteridines,” in Photorhabdus luminescens. The pepteridines are produced only in a phenotypic variant associated with bacterial pathogenesis and not in the variant associated with mutualistic colonization. Genetics and proteomics further supported that the pathway was under the control of a LysR-type regulator associated with the mutualist-pathogen transition and affected the regulation of proteins that govern pyrone quorum sensing and other defensive genetic loci. See also Yale West Campus News.

February, 2017. Congrats Hyun Bong, Parthasarathy, Corey, Joon Ha, and Jeannie on your paper being accepted to J. Biol. Chem. This was a multi-group collaboration with Steven Almo, Elissa Hallem, and Jeffrey Bonanno. The paper describes the X-ray structure and biochemical characterization of an orphan FAD-dependent monooxygenase that catalyzes the stereoselective epoxidation of stilbenes in Photorhabdus luminescens. Stilbenes participate in antibiosis, immunomodulation, and nematode developmental biology in this system. The newly described (bio)chemistry was examined in two distinct animal models. The data support a stilbene detoxification route in the bacteria-nematode symbiosis.  

February, 2017. Congrats Eric, Alan, and Emilee on your domain-targeted metabolomics paper being accepted to JACS. This paper combines multiplex automated genome engineering with pathway-targeted analyses to delineate the heterocycle assembly steps of colibactin biosynthesis. In addition to illuminating unexpected catalytic timing events in colibactin biosynthesis, the study also unveiled and structurally confirmed new reactive precolibactins. Upon peptidase treatment, these reactive metabolites were converted to a genotoxic scaffold consistent with the pathway’s genotoxic role associated with colorectal cancer. The domain-targeted metabolomics approach is general and could be widely applied to “multidomain” pathways for unprecedented genetic and metabolic precision analyses. See also the JACS Spotlight

January, 2017. Congrats Thomas, Stephanie, and Christina on your paper being accepted to ChemBioChem. This paper describes an “orphan” gene cluster in Legionella pneumophila, the causative agent of Legionnaires’ disease. The single gene cluster produces two distinct groups of aromatic amino acid-derived metabolites, including new N-acyl-amide and known isocyanide metabolites. One of the new N-acyl-amides harbored a cyclopropane moiety derived from cyclopropane fatty acid synthase. The paper also develops a general tetrazine-based chemoselective ligation approach to identify isocyanide-functionalized metabolites. 

December, 2016. Congrats Caleb on your paper being accepted to eLife. This paper shows how intermicrobial chemical exchange in the microbiome can regulate animal behaviors. Such interactions are missed in the more common single microbe metabolic studies. 

November, 2016. Congrats Alan, Herman, and Jaymin on your colibactin paper being accepted to JACS. This paper provides a robust mechanistic model for colibactin genotoxic reactivities and unifies the currently observed small molecule chemistry of the colibactin pathway. 

June, 2016. Congrats Hyun Bong, Corey, and Elena on your amicoumacin paper being accepted to Molecules. This paper illuminates a new amicoumacin antibiotic resistance mechanism and also provides the first mode of action insights for N-acyl-D-Asn pro-drug motifs in nonribosomal peptide-polyketide hybrid metabolites.

June, 2016. Congrats Hyun Bong on your pyrazinone paper being accepted to J. Antibiot. This paper demonstrates that novel pyrazinones in Photorhabdus pathogens are only produced in a phenotypic variant associated with pathogenesis and provides new insights for how this class of protease inhibitors may participate in host-bacteria interactions.

May, 2016. We welcome Tyler Goddard to the lab as a Chemical Biology graduate student from Baylor University.

May, 2016. We welcome Phu Khat Nwe to the lab as a Chemical Biology graduate student from Albion College.

May, 2016. We welcome Jhe-Hao Li to the lab as a Chemical Biology graduate student from the National Taiwan University.

April, 2016. We welcome Chung Sub Kim to the lab as a postdoctoral associate from the Kang Ro Lee lab at the Sungkyunkwan University. 

March, 2016. Congratulations Emilee Shine on receiving a NSF Graduate Research Fellowship.

March, 2016. Congratulations Alan and Maria on your precolibactin synthesis paper being published in JACS. This paper demonstrates that the colibactin warhead undergoes a cyclization cascade,  assembling from acyclic precursors, and that the colibactin peptidase can process advanced precolibactin C into N-myristoyl-D-Asn and colibactin C.

February, 2016. We welcome Christina Cho to the lab as a Chemistry graduate student from Macaulay Honors College at Queens College. We also welcome Helen Zhao as an undergraduate researcher in the lab. 

January, 2016. Congratulations Jason for receiving a Damon Runyon-Rachleff Innovation Award. Go “M-PAIR” cancer team! 

October, 2015. We welcome Joonseok Oh to the lab as a postdoctoral associate from the Hamann lab at the University of Mississippi.

July, 2015. We welcome Nam Kim to the lab as a Chemical Biology graduate student from the Johns Hopkins University.

June, 2015. We welcome Emilee Shine to the lab as a BBS graduate student from the University of Pittsburgh.

April, 2015. Congratulations to the lab for its successful Yale Cancer Center Pilot Project grant. 

April, 2015. Congratulations Hyun Bong on your Lumiquinone A discovery paper being accepted to J. Nat. Prod. This paper was the first to demonstrate that aminomalonate extender units can compete with malonate extender units in vivo for polyketide structural diversification, leading to the discovery of a new antibacterial aminobenzoquinone. 

April, 2015. See the very nice News & Views about our colibactin work by Eric Schmidt. See the very nice F1000 recommendation by Gong-Li Tang. See also the YaleNews article.

March, 2015. We welcome Jaymin Patel to the lab as a BBS graduate student from Yale. We also welcome undergrads Molly Mullen and Andy Wingerson to the lab.

February, 2015. Congratulations to Maria on your colibactin structure, biosynthesis, and activity paper being accepted to Nature Chem. It is nice to see the work heading to print since its submission in November, 2014.  Link

December, 2014. Congrats Philipp on your discovery of a divergent colibactin genomic island with genotoxic activity and its publication in AEM. This paper provided the first bioinformatic evidence (accelerated evolution and structural models of “deteriorated” acyl-transferase (AT) domains) that the “trans-AT” polyketide synthases in the colibactin pathway were derived from “cis-AT” ancestors. The colibactin pathway appears to be an “exception to the rule” for the generally independent evolution of trans-AT polyketide synthase pathways.

September, 2014. See YaleNews article about our recent Chem. Biol. paper on discovering new bioactive molecules from atypical genomic islands. This paper demonstrates that novel metabolic chemistry and biology can be accessed through genome synteny analysis and a reduced reliance on known protein homologies.

June, 2014. Congrats Maria on your “pathway-targeted” molecular networking study of the colibactin pathway and it being accepted to JACS. This paper provided a detailed molecular map of the pathway, elucidated the structure of the first authentic precolibactin truncation product (among others), and showed that it was an authentic substrate for the colibactin peptidase. The paper also provided a revision of the domain architecture for the pathway, including a previously missed dehydratase domain and a series of “deteriorated” acyl-transferase (AT) domains in the “trans-AT” polyketide synthases. Lastly, the study shows that N-myristoyl-D-Asn, a N-acyl-amide, inhibits hydroxytryptamine GPCR 5-HT7 and the dopamine D5 transporter.

May, 2014. Congratulations Zachary Gardner (Yale, ‘17) for being selected in to the Yale College Freshman Summer Research Fellowship in the Sciences and Engineering Program. We also congratulate Enoch Chang (Yale, ‘16) for being selected for a Yale Dean’s Fellowship. 

April, 2014. We welcome Thomas Tørring as a Carlsberg Foundation postdoctoral fellow from Kurt Vesterager Gothelf’s lab at the Center for DNA Nanotechnology & iNANO, University of Aarhus.

April, 2014. We welcome Yick Chong Lam as a Chemical Biology graduate student in the lab from the University of Rochester.

December, 2013. See Yale undergraduate Jacob Allen’s thoughtful article about our lab’s research. Allen, Jacob. December 24, 2013. Yale Scientific MagazineMining for Drugs: The Search for Natural Treatment Products.

September, 2013. Congratulations Jason for being selected as a 2013 National Institutes of Health New Innovator. Go cancer team!

April, 2013. We welcome Hyun Bong Park as a postdoc from Hak Cheol Kwon’s lab at the Korea Institute of Science and Technology.

April, 2013. We welcome Corey Perez as a Chemical Biology graduate student researcher in the lab from Columbia University.

April, 2013. Congratulations Jerry Cui (Yale, ‘16) and Enoch Chang (Yale, ‘16) for being selected in to the Yale College Freshman Summer Research Fellowship in the Sciences and Engineering Program. 

December, 2012. We welcome Eric Trautman as a Chemical Biology graduate student from Berkeley.

June, 2012. We welcome Xun Guo as a postdoc from Ben Shen’s lab at the Scripps Research Institute.

April, 2012. Congratulations Jason for receiving a Dale F. Frey Award for Breakthrough Scientists through the Damon Runyon Cancer Research Foundation.

April, 2012. The Crawford lab received its NIH R00 funds as part of Jason’s National Institutes of Health Pathway to Independence Award, and the lab is now open for business.